-CNBC’s “Fast Money: Halftime Report”
Teva And MedinCell Receive Complete Response Letter For TV-46000/mdc-IRM; Teva Shares Move Lower
Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and MedinCell (Euronext: MEDCL) announced that the U.S. Food and Drug Administration ("FDA") has issued a